Cargando…
Rare and potentially pathogenic variants in hydroxycarboxylic acid receptor genes identified in breast cancer cases
BACKGROUND: Three genes clustered together on chromosome 12 comprise a group of hydroxycarboxylic acid receptors (HCARs): HCAR1, HCAR2, and HCAR3. These paralogous genes encode different G-protein coupled receptors responsible for detecting glycolytic metabolites and controlling fatty acid oxidation...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8638184/ https://www.ncbi.nlm.nih.gov/pubmed/34852802 http://dx.doi.org/10.1186/s12920-021-01126-3 |
_version_ | 1784608900434100224 |
---|---|
author | McGuire Sams, Cierla Shepp, Kasey Pugh, Jada Bishop, Madison R. Merner, Nancy D. |
author_facet | McGuire Sams, Cierla Shepp, Kasey Pugh, Jada Bishop, Madison R. Merner, Nancy D. |
author_sort | McGuire Sams, Cierla |
collection | PubMed |
description | BACKGROUND: Three genes clustered together on chromosome 12 comprise a group of hydroxycarboxylic acid receptors (HCARs): HCAR1, HCAR2, and HCAR3. These paralogous genes encode different G-protein coupled receptors responsible for detecting glycolytic metabolites and controlling fatty acid oxidation. Though better known for regulating lipid metabolism in adipocytes, more recently, HCARs have been functionally associated with breast cancer proliferation/survival; HCAR2 has been described as a tumor suppressor and HCAR1 and HCAR3 as oncogenes. Thus, we sought to identify germline variants in HCAR1, HCAR2, and HCAR3 that could potentially be associated with breast cancer risk. METHODS: Two different cohorts of breast cancer cases were investigated, the Alabama Hereditary Cancer Cohort and The Cancer Genome Atlas, which were analyzed through nested PCRs/Sanger sequencing and whole-exome sequencing, respectively. All datasets were screened for rare, non-synonymous coding variants. RESULTS: Variants were identified in both breast cancer cohorts, some of which appeared to be associated with breast cancer BC risk, including HCAR1 c.58C > G (p.P20A), HCAR2 c.424C > T (p.R142W), HCAR2 c.517_518delinsAC (p.G173T), HCAR2 c.1036A > G (p.M346V), HCAR2 c.1086_1090del (p.P363Nfs*26), HCAR3 c.560G > A (p.R187Q), and HCAR3 c.1117delC (p.Q373Kfs*82). Additionally, HCAR2 c.515C > T (p.S172L), a previously identified loss-of-function variant, was identified. CONCLUSIONS: Due to the important role of HCARs in breast cancer, it is vital to understand how these genetic variants play a role in breast cancer risk and proliferation and their consequences on treatment strategies. Additional studies will be needed to validate these findings. Nevertheless, the identification of these potentially pathogenic variants supports the need to investigate their functional consequences. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12920-021-01126-3. |
format | Online Article Text |
id | pubmed-8638184 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-86381842021-12-02 Rare and potentially pathogenic variants in hydroxycarboxylic acid receptor genes identified in breast cancer cases McGuire Sams, Cierla Shepp, Kasey Pugh, Jada Bishop, Madison R. Merner, Nancy D. BMC Med Genomics Research Article BACKGROUND: Three genes clustered together on chromosome 12 comprise a group of hydroxycarboxylic acid receptors (HCARs): HCAR1, HCAR2, and HCAR3. These paralogous genes encode different G-protein coupled receptors responsible for detecting glycolytic metabolites and controlling fatty acid oxidation. Though better known for regulating lipid metabolism in adipocytes, more recently, HCARs have been functionally associated with breast cancer proliferation/survival; HCAR2 has been described as a tumor suppressor and HCAR1 and HCAR3 as oncogenes. Thus, we sought to identify germline variants in HCAR1, HCAR2, and HCAR3 that could potentially be associated with breast cancer risk. METHODS: Two different cohorts of breast cancer cases were investigated, the Alabama Hereditary Cancer Cohort and The Cancer Genome Atlas, which were analyzed through nested PCRs/Sanger sequencing and whole-exome sequencing, respectively. All datasets were screened for rare, non-synonymous coding variants. RESULTS: Variants were identified in both breast cancer cohorts, some of which appeared to be associated with breast cancer BC risk, including HCAR1 c.58C > G (p.P20A), HCAR2 c.424C > T (p.R142W), HCAR2 c.517_518delinsAC (p.G173T), HCAR2 c.1036A > G (p.M346V), HCAR2 c.1086_1090del (p.P363Nfs*26), HCAR3 c.560G > A (p.R187Q), and HCAR3 c.1117delC (p.Q373Kfs*82). Additionally, HCAR2 c.515C > T (p.S172L), a previously identified loss-of-function variant, was identified. CONCLUSIONS: Due to the important role of HCARs in breast cancer, it is vital to understand how these genetic variants play a role in breast cancer risk and proliferation and their consequences on treatment strategies. Additional studies will be needed to validate these findings. Nevertheless, the identification of these potentially pathogenic variants supports the need to investigate their functional consequences. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12920-021-01126-3. BioMed Central 2021-12-01 /pmc/articles/PMC8638184/ /pubmed/34852802 http://dx.doi.org/10.1186/s12920-021-01126-3 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Article McGuire Sams, Cierla Shepp, Kasey Pugh, Jada Bishop, Madison R. Merner, Nancy D. Rare and potentially pathogenic variants in hydroxycarboxylic acid receptor genes identified in breast cancer cases |
title | Rare and potentially pathogenic variants in hydroxycarboxylic acid receptor genes identified in breast cancer cases |
title_full | Rare and potentially pathogenic variants in hydroxycarboxylic acid receptor genes identified in breast cancer cases |
title_fullStr | Rare and potentially pathogenic variants in hydroxycarboxylic acid receptor genes identified in breast cancer cases |
title_full_unstemmed | Rare and potentially pathogenic variants in hydroxycarboxylic acid receptor genes identified in breast cancer cases |
title_short | Rare and potentially pathogenic variants in hydroxycarboxylic acid receptor genes identified in breast cancer cases |
title_sort | rare and potentially pathogenic variants in hydroxycarboxylic acid receptor genes identified in breast cancer cases |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8638184/ https://www.ncbi.nlm.nih.gov/pubmed/34852802 http://dx.doi.org/10.1186/s12920-021-01126-3 |
work_keys_str_mv | AT mcguiresamscierla rareandpotentiallypathogenicvariantsinhydroxycarboxylicacidreceptorgenesidentifiedinbreastcancercases AT sheppkasey rareandpotentiallypathogenicvariantsinhydroxycarboxylicacidreceptorgenesidentifiedinbreastcancercases AT pughjada rareandpotentiallypathogenicvariantsinhydroxycarboxylicacidreceptorgenesidentifiedinbreastcancercases AT bishopmadisonr rareandpotentiallypathogenicvariantsinhydroxycarboxylicacidreceptorgenesidentifiedinbreastcancercases AT mernernancyd rareandpotentiallypathogenicvariantsinhydroxycarboxylicacidreceptorgenesidentifiedinbreastcancercases |